D-1088-2017 Class III Terminated

Recalled by Akorn Inc — Lake Forest, IL

FDA drug recall D-1088-2017 was initiated by Akorn Inc on Jul 12, 2017 and is designated Class III. Reason for recall: Crystallization with subpotent out of specification assay results for chlorhexidine. The recall status is terminated (terminated Jun 19, 2018). Affected quantity: 541,900 unit dose cups (5,419 trays).

Recall details

Product Type
Drugs
Report Date
Aug 23, 2017
Initiation Date
Jul 12, 2017
Termination Date
Jun 19, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
541,900 unit dose cups (5,419 trays)

Product description

Chlorhexidine Gluconate Oral Rinse, 0.12%, 15 mL Unit Dose Cup, a) unit dose cup (NDC 50383-720-15), b) 100-count tray (NDC 50383-720-19), Rx Only, Hi-Tech Pharmacal Co. Inc., Amityville, NY 11701.

Reason for recall

Crystallization with subpotent out of specification assay results for chlorhexidine.

Distribution pattern

Nationwide in the USA

Code information

Lot: 353394, Exp 10-2018

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1088-2017
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1088-2017. Report a data issue: hello@regdatalab.com.